Clinical update: Cerner oncology

Come join us for a deep dive into the Cerner oncology road map, how-to guidance, solution features and industry trends. Get current on Cerner innovations that can help you address current and emerging initiatives and challenges. You can learn how the innovations impact data and workflows for department leaders and end users and engage with session presenters with real-time Q&A via the virtual chat feature.

 

Feyi Ayodele, MBA - CEO of Cancer IQ; Shareholder, Cancer IQ and Candace Westgate DO MPH FACOG: Myriad Genetics and Grail - consulting fees

The remaining speakers, content managers, and planners from Cerner Corporation do not have any relevant financial interests to disclose.

  • Session Type:Clinical special interest session
  • Learning objective 1:Identify new features that may be valuable to your end users and to your organization.
  • Learning objective 2:Discuss current experiences and best practices within workflows.
  • Learning objective 3:Apply learnings to address clinical challenges.
  • Content topics:Specialties, Service Line
  • Continuing education credits:ACPE, CME, CNE
  • Solutions:Oncology
  • Target audience:Informatics, Information Technology, Operations, Physician, Pharmacy, Clinical
click here to go back previous browser page Back